Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2026-01-02 @ 9:57 AM
Study NCT ID:
NCT02874404
Status:
COMPLETED
Last Update Posted:
2023-10-05
First Post:
2016-08-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
TGR-1202 and Ibrutinib in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor:
University of Nebraska
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-07
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-17
First Submit QC Date:
None
Study First Post Date:
2016-08-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-01-30
Results First Submit QC Date:
None
Results First Post Date:
2020-02-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-27
Last Update Post Date:
2023-10-05
Last Update Post Date Type:
ACTUAL